Efficacy of TIPS Plus Extrahepatic Collateral Embolisation in Real-world Data: a Validation Study

Overview

Journal BMJ Open Gastroenterol

Specialty Gastroenterology

Date 2024 Feb 23

PMID 38395452

Authors

Lianhui Zhao

Jun Tie

Guangchuan Wang

Zhengjie Li

Jiao Xu

Yuzheng Zhuge

Feng Zhang

Hao Wu

Bo Wei

Hui Xue

Peijie Li

Wei Wu

Chao Chen

Qiong Wu

Yifu Xia

Xiubin Sun

Chunqing Zhang

Affiliations

Soon will be listed here.

Abstract

Objectives: The efficacy of transjugular intrahepatic portosystemic shunt (TIPS) plus extrahepatic collateral embolisation (TIPS+E) in reducing rebleeding and hepatic encephalopathy (HE) post-TIPS was recently reported in a meta-analysis, but further validation is essential. This study aims to confirm the effectiveness of TIPS+E using real-world data.

Methods: The multicentre retrospective cohort included 2077 patients with cirrhosis who underwent TIPS±E (TIPS: 631, TIPS+E: 1446) between January 2010 and December 2022. Regression and propensity score matching (PSM) were used to adjust for baseline characteristic differences. After PSM, clinical outcomes, including rebleeding, HE, survival and further decompensation (FDC), were analysed. Baseline data from all patients contributed to the construction of prognostic models.

Results: After PSM, 1136 matched patients (TIPS+E: TIPS=568:568) were included. TIPS+E demonstrated a significant reduction in rebleeding (HR 0.77; 95% CI 0.59 to 0.99; p=0.04), HE (HR 0.82; 95% CI 0.68 to 0.99; p=0.04) and FDC (HR 0.85; 95% CI 0.73 to 0.99; p=0.04), comparing to TIPS. Significantly, TIPS+E also reduced rebleeding, HE and FDC in subgroup of using 8 mm diameter stents and embolising of gastric varices+spontaneous portosystemic shunts (GV+SPSS). However, there were no differences in overall or subgroup survival analysis. Additionally, the random forest models showed higher accuracy and AUROC comparing to other models. Controlling post-TIPS portal pressure gradient (pPPG) within 7 mm Hg<pPPG<8.5 mm Hg improved prognosis, especially in TIPS+E group.

Conclusion: Our real-world data validation confirms the high efficacy of TIPS+E in reducing rebleeding and HE, particularly when using 8 mm diameter stents, embolising GV+SPSS and maintaining an optimal pPPG.

References

Lv Y, Chen H, Luo B, Bai W, Li K, Wang Z . Concurrent large spontaneous portosystemic shunt embolization for the prevention of overt hepatic encephalopathy after TIPS: A randomized controlled trial. Hepatology. 2022; 76(3):676-688. DOI: 10.1002/hep.32453. View

Bosch J . Small diameter shunts should lead to safe expansion of the use of TIPS. J Hepatol. 2020; 74(1):230-234. DOI: 10.1016/j.jhep.2020.09.018. View

Silva-Junior G, Turon F, Baiges A, Cerda E, Garcia-Criado A, Blasi A . Timing Affects Measurement of Portal Pressure Gradient After Placement of Transjugular Intrahepatic Portosystemic Shunts in Patients With Portal Hypertension. Gastroenterology. 2017; 152(6):1358-1365. DOI: 10.1053/j.gastro.2017.01.011. View

Shah K, Ren A, Simpson R, Kloster M, Mikolajczyk A, Bui J . Combined Transjugular Intrahepatic Portosystemic Shunt Plus Variceal Obliteration versus Transjugular Intrahepatic Portosystemic Shunt Alone for the Management of Gastric Varices: Comparative Single-Center Clinical Outcomes. J Vasc Interv Radiol. 2021; 32(2):282-291.e1. DOI: 10.1016/j.jvir.2020.10.009. View

Zhou L, Zhong B, Du H, Wang W, Shen J, Zhang S . Comparison of embolic agents for varices during transjugular intrahepatic portosystemic shunt for variceal bleeding: Tissue gel or coil?. J Interv Med. 2021; 3(4):195-200. PMC: 8562183. DOI: 10.1016/j.jimed.2020.08.008. View

. EASL Clinical Practice Guidelines: Vascular diseases of the liver. J Hepatol. 2015; 64(1):179-202. DOI: 10.1016/j.jhep.2015.07.040. View

Lv Y, Wang Z, Li K, Wang Q, Bai W, Yuan X . Risk Stratification Based on Chronic Liver Failure Consortium Acute Decompensation Score in Patients With Child-Pugh B Cirrhosis and Acute Variceal Bleeding. Hepatology. 2020; 73(4):1478-1493. DOI: 10.1002/hep.31478. View

Shi Y, Tian X, Hu J, Zhang J, Zhang C, Yang Y . Efficacy of transjugular intrahepatic portosystemic shunt with adjunctive embolotherapy with cyanoacrylate for esophageal variceal bleeding. Dig Dis Sci. 2014; 59(9):2325-32. DOI: 10.1007/s10620-014-3150-2. View

Tripathi D, Bureau C . Prophylactic embolization of large spontaneous portosystemic shunts with transjugular intrahepatic portosystemic shunt (TIPS): A panacea for post-TIPS hepatic encephalopathy?. Hepatology. 2022; 76(3):551-553. DOI: 10.1002/hep.32525. View

10.

Lakhoo J, Bui J, Lokken R, Ray Jr C, Gaba R . Transjugular Intrahepatic Portosystemic Shunt Creation and Variceal Coil or Plug Embolization Ineffectively Attain Gastric Variceal Decompression or Occlusion: Results of a 26-Patient Retrospective Study. J Vasc Interv Radiol. 2016; 27(7):1001-11. DOI: 10.1016/j.jvir.2016.02.019. View

11.

Wolter K, Praktiknjo M, Boie J, Decker G, Nadal J, Jansen C . Glue Embolization of Gastroesophageal Varices during Transjugular Intrahepatic Portosystemic Shunt (TIPS) Improves Survival Compared to Coil-only Embolization-A Single-Center Retrospective Study. Cardiovasc Intervent Radiol. 2021; 44(8):1240-1250. PMC: 8249301. DOI: 10.1007/s00270-021-02852-y. View

12.

Xue H, Yuan J, Chao-Li Y, Palikhe M, Wang J, Shan-Lv L . Follow-up study of transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension. Dig Dis Sci. 2011; 56(11):3350-6. DOI: 10.1007/s10620-011-1744-5. View

13.

Gaba R, Omene B, Podczerwinski E, Knuttinen M, Cotler S, Kallwitz E . TIPS for treatment of variceal hemorrhage: clinical outcomes in 128 patients at a single institution over a 12-year period. J Vasc Interv Radiol. 2011; 23(2):227-35. DOI: 10.1016/j.jvir.2011.10.015. View

14.

De Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C . Baveno VII - Renewing consensus in portal hypertension. J Hepatol. 2022; 76(4):959-974. PMC: 11090185. DOI: 10.1016/j.jhep.2021.12.022. View

15.

Fagiuoli S, Bruno R, Debernardi Venon W, Schepis F, Vizzutti F, Toniutto P . Consensus conference on TIPS management: Techniques, indications, contraindications. Dig Liver Dis. 2016; 49(2):121-137. DOI: 10.1016/j.dld.2016.10.011. View

16.

Liu J, Yang C, Huang S, Zhou C, Shi Q, Qian K . The combination of balloon-assisted antegrade transvenous obliteration and transjugular intrahepatic portosystemic shunt for the management of cardiofundal varices hemorrhage. Eur J Gastroenterol Hepatol. 2020; 32(5):656-662. PMC: 7147412. DOI: 10.1097/MEG.0000000000001705. View

17.

Garcia-Tsao G, Abraldes J, Berzigotti A, Bosch J . Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology. 2016; 65(1):310-335. DOI: 10.1002/hep.28906. View

18.

. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018; 69(2):406-460. DOI: 10.1016/j.jhep.2018.03.024. View

19.

Tripathi D, Lui H, Helmy A, Dabos K, Forrest E, Stanley A . Randomised controlled trial of long term portographic follow up versus variceal band ligation following transjugular intrahepatic portosystemic stent shunt for preventing oesophageal variceal rebleeding. Gut. 2004; 53(3):431-7. PMC: 1773959. DOI: 10.1136/gut.2003.013532. View

20.

Yu J, Wang X, Jiang M, Ma H, Zhou Z, Yang L . Comparison of transjugular intrahepatic portosystemic shunt (TIPS) alone and combined with embolisation for the management of cardiofundal varices: a retrospective study. Eur Radiol. 2018; 29(2):699-706. DOI: 10.1007/s00330-018-5645-2. View